These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10498916)

  • 1. New therapeutic options for HIV patients.
    Hillery A
    Pharm Sci Technol Today; 1999 Oct; 2(10):389-390. PubMed ID: 10498916
    [No Abstract]   [Full Text] [Related]  

  • 2. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.
    Hatano H; Hunt P; Weidler J; Coakley E; Hoh R; Liegler T; Martin JN; Deeks SG
    Clin Infect Dis; 2006 Nov; 43(10):1329-36. PubMed ID: 17051502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New therapeutic options in protracted HIV-infected patients with virological failure].
    Moreno Cuerda VJ; Rubio García R; Morales Conejo M
    Med Clin (Barc); 2008 Jan; 130(2):66-70. PubMed ID: 18221677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric treatment issues.
    Walters S
    Int J Clin Pract Suppl; 1999 Jun; 103():26-9. PubMed ID: 10622040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment options.
    Lori F; Foli A; Lisziewicz J
    Curr Opin HIV AIDS; 2007 Jan; 2(1):14-20. PubMed ID: 19372860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practice.
    Imaz A; Falcó V; Ribera E
    AIDS Rev; 2011; 13(3):180-93. PubMed ID: 21799536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 transmission and survival according to feeding options in infants born to HIV-infected women in Yaoundé, Cameroon.
    Njom Nlend AE; Motaze ACN; Sandie A; Fokam J
    BMC Pediatr; 2018 Feb; 18(1):69. PubMed ID: 29458337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options.
    Kaufmann GR; Cooper DA
    Curr Opin Microbiol; 2000 Oct; 3(5):508-14. PubMed ID: 11050451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of antiretroviral treatment in HIV-infected patients exhibiting virologic failure].
    Pinganaud C; Goujard C
    Presse Med; 2002 Jun; 31(22):1034-40. PubMed ID: 12148259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving therapeutic paradigms for HIV and HCV.
    Molla A; Kohlbrenner W
    Curr Opin Biotechnol; 2003 Dec; 14(6):634-40. PubMed ID: 14662394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients.
    Riccardi N; Berruti M; Del Puente F; Taramasso L; Di Biagio A
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):190-197. PubMed ID: 30378502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescents and HIV: Controversies Old and New.
    Schonberg SK; Hoffman ND
    Adolesc Med; 1997 Oct; 8(3):463-471. PubMed ID: 10360028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
    De Luca A; Hamers RL; Schapiro JM
    J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for HIV-associated lymphomas.
    Spina M; Gloghini A; Tirelli U; Carbone A
    Expert Opin Pharmacother; 2010 Oct; 11(15):2471-81. PubMed ID: 20726820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in HIV positive patients.
    Nunnari G; Berretta M; Pinzone MR; Di Rosa M; Berretta S; Cunsolo G; Malaguarnera M; Cosentino S; De Paoli P; Schnell JM; Cacopardo B
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1257-70. PubMed ID: 23047511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options.
    Krishnan A; Zaia JA
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):584-9. PubMed ID: 25696915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.
    Jablonowski H
    Infection; 2003 Mar; 31(2):131-3. PubMed ID: 12749300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic options for HIV infection should lead to increased utilization of HIV tests].
    Coutinho RA; Hoogkamp-Korstanje JA; Danner SA
    Ned Tijdschr Geneeskd; 1999 Mar; 143(12):598-9. PubMed ID: 10321283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/AIDS: epidemic update, new treatment strategies and impact on autoimmunity.
    Croce F; Piconi S; Atzeni F; Sarzi-Puttini P; Galli M; Clerici M
    Clin Exp Rheumatol; 2008; 26(1 Suppl 48):S48-52. PubMed ID: 18570754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.